Device Trial Radar · NCT04804943
Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)
Last checked: Nov 20, 2026Latest source record: Jul 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
45
Planned (sponsor's estimate)
Start
May 22, 2021
Primary completion
Jun 30, 2025
Study completion Sep 4, 2025
Sponsor
- Lead sponsor
- Toray Industries, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 18, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary object of this clinical study is to investigate the efficacy and the safety of NOA-001 in patients with ARDS (ARDS caused by Non-COVID-19 or COVID-19).
Conditions
- Acute Respiratory Distress Syndrome
Interventions
NOA-001Device
NOA-001 will be replaced regularly (at 22 to 24 hours after the initiation of procedure), and will be continuously performed until 168 hours from the enrollment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ventilator Free Days (VFD, Days alive and ventilator-free)Time frame: Day 28
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Showa University Hospital
Tokyo, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.